Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05877417 · ClinicalTrials.gov registry record · NA
Blood Flow Restriction and Creatine Supplementation in Women
A NA study, sponsored by University of Central Florida.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT05877417 is a NA study that has completed, run by University of Central Florida. The registered enrollment target is 68 participants.
The verdict
NCT05877417, a NA study, has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
This research is examining the changes in muscle size, muscle function, body composition, strength, and blood vessel health. Specifically, the changes in these variables over the course of 8 weeks of training with or without blood flow restriction (BFR) and the supplementation of creatine or placebo (dextrose, a sugar in the form of a powder which is the standard placebo). Creatine monohydrate (Cr) is the most popular supplement for athletes and benefits all populations, however women are still very hesitant to take it due to the misconception of weight gain. This study will look to measure those muscle and body changes with exercise.
Interventions
- OTHER Exercise
- DIETARY_SUPPLEMENT Creatine Monohydrate
- DEVICE Blood Flow Restriction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2023-05-17 |
| Est. Completion | 2024-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05877417
The ClinicalTrials.gov registry entry for NCT05877417 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Exercise is the first listed.
NCT05877417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05877417 about?
NCT05877417 is a clinical study titled "Blood Flow Restriction and Creatine Supplementation in Women". This research is examining the changes in muscle size, muscle function, body composition, strength, and blood vessel health. Specifically, the changes in these variables over the course of 8 weeks of training with or without blood flow restriction (BFR) and the supplementation of creatine or placebo...
What is the current status of trial NCT05877417?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2023-05-17. Estimated completion is 2024-03-01.
What interventions are being tested in trial NCT05877417?
The interventions under investigation include: Exercise (OTHER), Creatine Monohydrate (DIETARY_SUPPLEMENT), Blood Flow Restriction (DEVICE).
Who is sponsoring clinical trial NCT05877417?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.